Relations of Measures of Endothelial Function and Kidney Disease: The Framingham Heart Study

American Journal of Kidney Diseases

Volumn 52, Issue 5, 2008, Pages 859-867

  Foster, Meredith C ^a,b   Keyes, Michelle J ^a   Larson, Martin G ^a   Vita, Joseph A ^c,d   Mitchell, Gary F ^e   Meigs, James B ^f   Vasan, Ramachandran S ^a,c,d   Benjamin, Emelia J ^a,c,d   Fox, Caroline S ^a,b,g  

^a FRAMINGHAM HEART STUDY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CARDIOVASCULAR ENGINEERING INC   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

brachial reactivity; Chronic kidney disease; cystatin C; Framingham Heart Study

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C;

ADULT; AGED; ARTICLE; BRACHIAL ARTERY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPEREMIA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; URINARY EXCRETION;

AGED; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED;

EID: 54349112439     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.04.027     Document Type: Article

References (52)

1. Coresh J., Astor B.C., Greene T., et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
2. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
3. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
4. Cheung A.K., Sarnak M.J., Yan G., et al. Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study. Kidney Int 65 (2004) 2380-2389
5. Foley R.N., Murray A.M., Li S., et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16 (2005) 489-495
6. Longenecker J.C., Coresh J., Powe N.R., et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J Am Soc Nephrol 13 (2002) 1918-1927
7. Wheeler D.C., Townend J.N., and Landray M.J. Cardiovascular risk factors in predialysis patients: Baseline data from the Chronic Renal Impairment in Birmingham (CRIB) Study. Kidney Int Suppl 84 (2003) S201-S203
8. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
9. Celermajer D.S., Sorensen K.E., Georgakopoulos D., et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88 (1993) 2149-2155
10. Celermajer D.S., Sorensen K.E., Bull C., et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24 (1994) 1468-1474
11. Clarkson P., Celermajer D.S., Powe A.J., et al. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation 96 (1997) 3378-3383
12. Schachinger V., Britten M.B., Elsner M., et al. A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation. Circulation 100 (1999) 1502-1508
13. Benjamin E.J., Larson M.G., Keyes M.J., et al. Clinical correlates and heritability of flow-mediated dilation in the community: The Framingham Heart Study. Circulation 109 (2004) 613-619
14. Yeboah J., Crouse J.R., Hsu F.C., et al. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: The Cardiovascular Health Study. Circulation 115 (2007) 2390-2397
15. Vita J.A., and Keaney Jr. J.F. Endothelial function: A barometer for cardiovascular risk?. Circulation 106 (2002) 640-642
16. Marin E., and Sessa W.C. Role of endothelial-derived nitric oxide in hypertension and renal disease. Curr Opin Nephrol Hypertens 16 (2007) 105-110
17. Passauer J., Pistrosch F., Bussemaker E., et al. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. J Am Soc Nephrol 16 (2005) 959-965
18. Segarra A., Chacon P., Martinez-Eyarre C., et al. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: Biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol 12 (2001) 1255-1263
19. Mallamaci F., Tripepi G., Cutrupi S., et al. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 67 (2005) 2330-2337
20. Mallamaci F., Zoccali C., Tripepi G., et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61 (2002) 609-614
21. Buccianti G., Baragetti I., Bamonti F., et al. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease. J Nephrol 17 (2004) 405-410
22. London G.M., Pannier B., Agharazii M., et al. Forearm reactive hyperemia and mortality in end-stage renal disease. Kidney Int 65 (2004) 700-704
23. Pannier B., Guerin A.P., Marchais S.J., et al. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 57 (2000) 1091-1099
24. Gris J.C., Branger B., Vecina F., et al. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 46 (1994) 807-813
25. Bolton C.H., Downs L.G., Victory J.G., et al. Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 16 (2001) 1189-1197
26. Jacobson S.H., Egberg N., Hylander B., et al. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 22 (2002) 42-47
27. van G.C., Janssen M.J., Lambert J., et al. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 13 (1998) 1782-1786
28. Morris S.T., McMurray J.J., Spiers A., et al. Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 60 (2001) 1077-1082
29. Ghiadoni L., Cupisti A., Huang Y., et al. Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol 17 (2004) 512-519
30. Annuk M., Lind L., Linde T., et al. Impaired endothelium-dependent vasodilatation in renal failure in humans. Nephrol Dial Transplant 16 (2001) 302-306
31. Haaber A.B., Eidemak I., Jensen T., et al. Vascular endothelial cell function and cardiovascular risk factors in patients with chronic renal failure. J Am Soc Nephrol 5 (1995) 1581-1584
32. Stam F., van G.C., Becker A., et al. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: The Hoorn Study. J Am Soc Nephrol 17 (2006) 537-545
33. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
34. Kannel W.B., Feinleib M., McNamara P.M., et al. An investigation of coronary heart disease in families. The Framingham Offspring Study. Am J Epidemiol 110 (1979) 281-290
35. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
36. Levey A.S., Greene T., Kusek J., et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 0828A (abstr)
37. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
38. Fox C.S., Larson M.G., Leip E.P., et al. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
39. Stevens L.A., Coresh J., Schmid C.H., et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51 (2008) 395-406
40. Nathan D.M., Rosenbaum C., and Protasowicki V.D. Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 10 (1987) 414-418
41. Bakker A.J. Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 22 (1999) 307-313
42. Mitchell G.F., Parise H., Vita J.A., et al. Local shear stress and brachial artery flow-mediated dilation: The Framingham Heart Study. Hypertension 44 (2004) 134-139
43. Lerman A., and Zeiher A.M. Endothelial function: Cardiac events. Circulation 111 (2005) 363-368
44. Gokce N., Keaney Jr. J.F., Hunter L.M., et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 105 (2002) 1567-1572
45. Huang A.L., Silver A.E., Shvenke E., et al. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 27 (2007) 2113-2119
46. Cupples L.A., and D'Agostino R.B. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Study, 30-year follow-up. In: Kannel W.B., and Garrison R.J. (Eds). The Framingham Heart Study: An Epidemiologic Investigation of Cardiovascular Disease (1987), Government Printing Office, NIH Publication, Washington DC 87-203 section 34
47. SAS Institute Inc: Version 8 (1999), SAS Institute, Cary, NC
48. Thambyrajah J., Landray M.J., McGlynn F.J., et al. Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83 (2000) 205-209
49. Landray M.J., Wheeler D.C., Lip G.Y., et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: The Chronic Renal Impairment in Birmingham (CRIB) Study. Am J Kidney Dis 43 (2004) 244-253
50. Rule A.D., Larson T.S., Bergstralh E.J., et al. Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med 141 (2004) 929-937
51. Stehouwer C.D., Gall M.A., Twisk J.W., et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death. Diabetes 51 (2002) 1157-1165
52. Nelson C.L., Karschimkus C.S., Dragicevic G., et al. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrol Dial Transplant 20 (2005) 2420-2426